NFCA Webinars are geared for those with celiac disease and other gluten-related disorders as well as the dietitians and providers who serve them. Thanks to the support of sponsors, these Webinars continue to be free of charge!
If you have a Webinar idea or topic you'd like to see discussed, please contact email@example.com.
Note: A recording of each Webinar will be posted along with the Webinar slides within 72 hours after the live Webinar ends. To download recorded Webinars and slides, visit the Archived Webinars page.
Click here to see the 2015 webinar schedule.
Don't Just Go Gluten-Free: Why You Need to be Tested First
Tuesday, January 27, 2015
8 p.m. to 9 p.m. EST/5 p.m. to 6 p.m. PST
With the rise of the gluten-free fad, people often choose to skip testing for celiac disease and immediately start on a gluten-free diet. What is left out of the conversation far too often is the fact that 1 in 133 Americans medically require a gluten-free diet – it is currently the only available treatment for celiac disease, a serious genetic autoimmune condition. For these people, it is not a choice, it is a prescription. So, don’t just go gluten-free before you learn all the facts! Learn why it is essential that you be tested before going gluten-free, and why an accurate celiac disease diagnosis will help you in the long run. Join NFCA and Dr. Benjamin Lebwohl of the Celiac Disease Center at Columbia University as we discuss the need for and benefits of being tested for celiac disease.
About the Panelist
Dr. Benjamin Lebwohl, Celiac Disease Center at Columbia University
Dr. Lebwohl is a graduate of Harvard College, where he majored in music. He received his MD from Columbia College of Physicians and Surgeons in 2003, and then completed his internship, residency, and chief residency in internal medicine at Columbia. He stayed at Columbia as a fellow in Digestive and Liver Disease, during which time he obtained a Masters in Patient Oriented Research from the Department of Biostatistics at the Mailman School of Public Health. He was a post-doctoral fellow in a National Cancer Institute-funded Training Program in Cancer-Related Population Sciences under the mentorship of Alfred Neugut. He joined the faculty of the Celiac Disease Center at Columbia University in 2010.
Dr. Lebwohl is an Irving Scholar (2013-2016), studying the influence of the gastric environment on the development of celiac disease. He is also a Gerstner Scholar (2014-2017), studying the impact of gluten exposure on the microbiome in patients with celiac disease and non-celiac gluten sensitivity. He is the recipient of the American Gastroenterology Association Research Scholar Award (2014-2017), in which he is collaborating with the Channing Laboratory at Harvard to study risk factors for celiac disease and the health effects of gluten in large cohort studies. He is an associated scholar at the Karolinska Institute in Stockholm, Sweden, where he performs population-based research in celiac disease in the Department of Medical Epidemiology and Biostatistics.